Vice President, Global Head of Precision Medicine and Diagnostics @ (October 2023 - October 2025)
Vice President, Head of Translational Medicine and Translational Science Labs @ (April 2022 - October 2023)
Senior Director, Head of Translational Labs and Clinical Biomarkers @ (January 2019 - April 2022)
Associate Director in Lead Discovery, Oncology @ (January 2017 - January 2018)
Principal Scientist in Lead Discovery, Oncology @ (January 2015 - January 2017)
Senior Research Investigator II in Lead Discovery, Oncology @ (January 2013 - January 2015)
Senior Research Investigator I in Lead Discovery, Oncology @ (July 2011 - January 2013)
Postdoctoral Fellow; Hematopoietic Malignancies @ (July 2008 - June 2011)
PhD Tumor Biology (Pancreatic and Breast) @ (September 2002 - June 2008)
Lead Drug Discovery, Immunology @ (May 1999 - May 2002)
Associate Scientist-Inflammatory Disease Research Group @ (May 1999 - August 1999)
Mark Fereshteh Education
Duke University
Postdoctoral Fellow (Pharmacology & Cancer Biology)
2008-2011
Georgetown University
PhD (Tumor Biology)
2002-2008
Mark Fereshteh Summary
Mark Fereshteh, based in New York, NY, US, is currently a Chief Scientific Officer at Pathos. Mark Fereshteh brings experience from previous roles at Genmab and Bristol-Myers Squibb. Mark Fereshteh holds a 2008 - 2011 Postdoctoral Fellow in Pharmacology & Cancer Biology @ Duke University. Mark Fereshteh has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Mark Fereshteh?
Find contact details for 700 million professionals.